Literature DB >> 12610016

Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans.

Tomoshige Hayashi1, Edward J Boyko, Donna L Leonetti, Marguerite J McNeely, Laura Newell-Morris, Steven E Kahn, Wilfred Y Fujimoto.   

Abstract

OBJECTIVE: Greater visceral adiposity, higher insulin resistance, and impaired insulin secretion increase the risk of type 2 diabetes. Whether visceral adiposity increases risk of impaired glucose tolerance (IGT) independent of other adipose depots, insulin resistance, and insulin secretion is not known. RESEARCH DESIGN AND METHODS: Study subjects included 128 Japanese Americans with normal glucose tolerance at entry. Baseline variables included plasma glucose and insulin measured after an overnight fast and during a 75-g oral glucose tolerance test, fat areas by computed tomography, insulin secretion (incremental insulin response [IIR] [30 min insulin - fasting insulin]/30 min glucose), and insulin resistance index (homeostasis model assessment for insulin resistance [HOMA-IR]).
RESULTS: During the 10- to 11-year follow-up period, we confirmed 57 cases of IGT. Significant predictors of IGT included intra-abdominal fat area (IAFA) (odds ratio [OR] for a 1 SD increase 3.82, 95% CI 1.63-8.94 at a fasting plasma glucose [FPG] level of 4.5 mmol/l), HOMA-IR (2.41, 1.15-5.04), IIR (0.30, 0.13-0.69 at an FPG level of 4.5 mmol/l), the interactions of IAFA by FPG (P = 0.003), and IIR by FPG (P = 0.030) after adjusting for age, sex, FPG, and BMI. The multiple-adjusted OR of IAFA increased and that of IIR decreased as FPG level decreased because of these interactions. Even after adjustment for total fat area, total subcutaneous fat area, or abdominal subcutaneous fat area, all of these associations remained a significant predictor of IGT incidence.
CONCLUSIONS: Greater visceral adiposity increases the risk of IGT independent of insulin resistance, insulin secretion, and other adipose depots in Japanese Americans.

Entities:  

Mesh:

Year:  2003        PMID: 12610016     DOI: 10.2337/diacare.26.3.650

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  76 in total

1.  Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study.

Authors:  Lauren J Kim; Michael A Nalls; Gudny Eiriksdottir; Sigurdur Sigurdsson; Lenore J Launer; Annemarie Koster; Paulo H M Chaves; Birna Jonsdottir; Melissa Garcia; Vilmundur Gudnason; Tamara B Harris
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

2.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

3.  Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates.

Authors:  Pandora L Wander; Tomoshige Hayashi; Kyoko Kogawa Sato; Shinichiro Uehara; Yonezo Hikita; Donna L Leonetti; Steven E Kahn; Wilfred Y Fujimoto; Edward J Boyko
Journal:  J Diabetes Complications       Date:  2018-09-11       Impact factor: 2.852

4.  Early maternal circulating alkaline phosphatase with subsequent gestational diabetes mellitus and glucose regulation: a prospective cohort study in China.

Authors:  Ting Xiong; Chunrong Zhong; Guoqiang Sun; Xuezhen Zhou; Renjuan Chen; Qian Li; Yuanjue Wu; Qin Gao; Li Huang; Xingwen Hu; Mei Xiao; Xuefeng Yang; Liping Hao; Nianhong Yang
Journal:  Endocrine       Date:  2019-05-21       Impact factor: 3.633

5.  Worse cardiometabolic health in African immigrant men than African American men: reconsideration of the healthy immigrant effect.

Authors:  Michelle Y O'Connor; Caroline K Thoreson; Madia Ricks; Amber B Courville; Francine Thomas; Jianhua Yao; Peter T Katzmarzyk; Anne E Sumner
Journal:  Metab Syndr Relat Disord       Date:  2014-05-09       Impact factor: 1.894

Review 6.  Clinical assessment and management of obesity in individuals with spinal cord injury: a review.

Authors:  Suparna Rajan; Marguerite J McNeely; Catherine Warms; Barry Goldstein
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

7.  Association of visceral and subcutaneous adiposity with kidney function.

Authors:  Jill A Young; Shih-Jen Hwang; Mark J Sarnak; Udo Hoffmann; Joseph M Massaro; Daniel Levy; Emelia J Benjamin; Martin G Larson; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

Review 8.  Chronic inflammation in obesity and the metabolic syndrome.

Authors:  Rosário Monteiro; Isabel Azevedo
Journal:  Mediators Inflamm       Date:  2010-07-14       Impact factor: 4.711

9.  Visceral and subcutaneous adiposity and brachial artery vasodilator function.

Authors:  Nisha I Parikh; Michelle J Keyes; Martin G Larson; Karla M Pou; Naomi M Hamburg; Joseph A Vita; Christopher J O'Donnell; Ramachandran S Vasan; Gary F Mitchell; Udo Hoffmann; Caroline S Fox; Emelia J Benjamin
Journal:  Obesity (Silver Spring)       Date:  2009-03-12       Impact factor: 5.002

10.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.